Introduction {#sec1}
============

Osteoarthritis (OA) is a major cause of pain and disability worldwide[@bib1], [@bib2]. Most patients with clinical OA are seen and managed in primary care, and the UK National Institute for Health and Care Excellence (NICE) has identified a set of core interventions which can be offered to all patients consulting with OA in primary care. Yet much primary care for OA patients in the UK does not adhere to NICE guidance, including the core items of education and information provision, and advice and referral for exercise and weight management[@bib1], [@bib3], [@bib4], [@bib5], [@bib6]. Internationally, the situation is similar[@bib7], [@bib8] and a change in models of care for OA has been proposed[@bib9].

A systematic review has previously identified some limited evidence to support primary care collaborative care models and multidisciplinary case management as complex interventions to improve OA care[@bib10]. Strategies to improve quality of primary care for long-term conditions in the UK have included use of computerised templates and decision support systems[@bib11], health trainers[@bib12], promotion of self-management[@bib13], and educational intervention[@bib14]. Although some risk factors for OA are addressed by the health trainer model (weight management, exercise/physical activity), there have been few successful attempts to enhance OA care in general practice.

The MOSAICS (Managing OSteoArthritis In ConsultationS) study was a cluster randomised controlled trial to test a complex patient-focused intervention, namely a model OA consultation during which the core NICE OA recommendations are delivered. This was developed using the Whole Systems Informing Self-Management Engagement (WISE) model[@bib15] and incorporated an OA Guidebook developed with user involvement, an enhanced OA consultation, and access to a practice based nurse-led OA clinic[@bib16], [@bib17]. The MOSAICS study aimed to assess:•The effectiveness of the intervention on the quality of primary care for patients aged ≥45 years consulting with clinical OA.•The impact, feasibility and acceptability of the model OA consultation in primary care.

We report here the practice-level results addressing the study question of whether the intervention (model OA consultation) increases the uptake of NICE OA recommendations by general practices taking part in MOSAICS, as measured by quality indicators of OA care in the practices\' electronic health records (EHR). A quality indicator was defined as "*a measurable element of practice performance for which there is evidence or consensus that it can be used to assess the quality, and hence change in the quality, of care provided*"[@bib18]. We also report on adverse events.

Methods {#sec2}
=======

Study design {#sec2.1}
------------

MOSAICS was a mixed methods study with a two arm cluster randomised controlled trial conducted in eight general practices in Cheshire, Shropshire, or Staffordshire, UK. The protocol has been published[@bib17] and the patient-level self-reported outcomes for clinical effectiveness will be reported elsewhere.

The MOSAICS study has two key parts: a population survey that took place between May 2011 and April 2012 and a cluster randomised trial that was conducted from May 2012 to February 2014 by the Arthritis Research UK Primary Care Centre, Keele University, UK. The study was approved by the North West 1 Research Ethics Committee, Cheshire (REC reference: 10/H1017/76) and monitored by an Independent Trial Steering Committee and Data Monitoring Committee.

Cluster randomisation at the practice level was used to prevent contamination by clinicians as it was expected GPs would be unable to manage patients allocated to the control arm differently to those allocated to the intervention arm. It may also better develop a community of practice for OA care within a cluster. The evaluation of the intervention used anonymised medical records to allow the analysis of the management and care of a large number of patients without recruitment bias and the attrition and non-consent issues of self-reported patient evaluation. By using medical record information for measuring the outcomes, all eligible patients in the practices were included.

Participants {#sec2.2}
------------

Practices which were members of the Central England Primary Care Research Network or a Keele Research Network Practice, and used the EMIS computerised system were approached sequentially until eight agreed to take part. Ten general practices were invited to participate. Reasons for non-participation were recent engagement with teaching medical students and involvement with other research[@bib19].

All health care professionals (general practitioners and practice nurses) from the eight randomised practices and their respective practice populations aged ≥45 years consulting with clinical OA (diagnosed OA or recorded peripheral joint pain) formed the sampling frame for the cluster trial.

During a six month baseline period prior to randomisation, all practices received a resource pack of written advice for patients, with examples of OA leaflets provided by Arthritis Research UK, Arthritis Care and NICE. Training of health care professionals in the trial intervention occurred after randomisation.

Patients eligible for inclusion were aged ≥45 years and had at least one consultation recorded as clinical OA defined as an OA diagnostic Read code or a code for joint pain (hand/wrist, hip, knee, foot/ankle) during the study period. In UK primary care, morbidities are generally entered using Read Codes, a hierarchical coding system structured into chapters. For example, codes under Chapter N represent 'Musculoskeletal and Connective Tissue Diseases'. GPs may often enter symptom codes rather than diagnosis codes and using only OA diagnostic Read codes means patients presenting with OA symptoms will be missed[@bib20], [@bib21]. Joint pain codes likely to represent OA had previously been determined by six academic general practitioners with an interest in musculoskeletal conditions[@bib22]. The current analysis was performed on the anonymised EHR data of all patients fulfilling the eligibility criteria.

Randomisation {#sec2.3}
-------------

Following the six month baseline period, practices were randomised into intervention (model OA consultation, four practices) or to continue with usual care (four practices). Practices were randomly allocated, stratified by practice list size, by administrative staff at the Keele Clinical Trials Unit who had no clinical involvement in the trial. The trial statisticians were kept blind to the allocation until after the analysis.

Intervention {#sec3}
============

The model OA consultation {#sec3.1}
-------------------------

The development of the intervention has been published elsewhere[@bib17], [@bib23], [@bib24]. Briefly, using the findings of two consensus exercises[@bib23], [@bib25] and theoretical models to guide self-management[@bib26] and support patient behaviour change[@bib27], [@bib28], a model OA consultation was developed. This comprised an enhanced initial consultation with the GP and provision of a nurse-led OA clinic, both supported by use of an OA Guidebook, and was delivered to patients aged ≥45 years presenting with clinical OA ([Appendix 1](#appsec1){ref-type="sec"}).

Training {#sec3.2}
--------

Training and educational packages were developed by drawing on Michie *et al.*[@bib28], [@bib29]. Intervention practices received practice updates on core NICE recommendations for OA (diagnosis; written information \[the OA guidebook\], exercise and physical activity, healthy eating, pain management). GPs received training on how to deliver the initial consultation for new or established OA patients during four sessions (2 h ×3, 1 h ×1) utilizing simulated patients in skills training sessions[@bib16]. The procedure for referring to a practice nurse for a follow-up OA consultation was discussed. Practice nurses received four days of training on how to support and enable patients to self-manage OA, using a patient-centred approach, the OA guidebook, goal setting, pain management (analgesia and exercise) and the core NICE recommendations (information and advice, strengthening exercise and aerobic fitness training, and weight management)[@bib30].

Control practices received no training, guidebook or OA nurse clinic, and continued usual care alongside the resource pack of written advice for patients given in the pre-randomisation baseline period.

Outcomes {#sec3.3}
--------

The outcomes were the recorded achievement (achieved vs not achieved) of fourteen quality indicators of care for patients presenting with clinical OA during the six month period after randomisation and training. This was assessed through the use of quality indicators derived from a systematic review[@bib31] with additional measures derived from the NICE OA guidelines ([Box 1](#tbox1){ref-type="boxed-text"})[@bib1]. They cover four domains: assessment (pain, function, body mass index (BMI), X-ray use), core management (OA information, exercise advice, weight loss advice), other non-pharmacological management (physiotherapy referral), and pharmacological management (paracetamol, topical non-steroidal anti-inflammatory drugs (NSAIDs), gastroprotection). For the core management indicators, indicator achievement was defined as the information being given verbally, written, or deemed by the clinician as not appropriate. However, we also assessed whether there had been increases in the level of written information and advice as this is the core NICE recommendation[@bib1].Box 1Quality indicators of primary care of osteoarthritisDomainQuality indicatorIndicator source[∗](#tbox1fnlowast){ref-type="table-fn"}Data sourceEvidence of achievementChange signalling care improved[†](#tbox1fndagger){ref-type="table-fn"}AssessmentPain assessedReviewe-TemplateRecorded level of pain[‡](#tbox1fnddagger){ref-type="table-fn"}IncreaseFunction assessedReviewe-TemplateRecorded level of function[‡](#tbox1fnddagger){ref-type="table-fn"}IncreaseBMI measurement/weight recordReviewe-Template & routine EHRRecorded BMI or weightIncreaseX-ray requestedGuidelineRoutine EHRRecorded X-ray of knee, hip, hand, or footDecreaseCore interventionsOA informationReviewe-TemplateRecorded as verbal or written; or not appropriate[∗∗](#tbox1fnlowastlowast){ref-type="table-fn"}Increase Written OA informationGuidelinee-TemplateRecorded as writtenIncreaseExercise adviceReviewE-TemplateRecorded as verbal or written; or not necessary or not appropriate[∗∗](#tbox1fnlowastlowast){ref-type="table-fn"}Increase Written exercise adviceGuidelinee-TemplateRecorded as writtenIncreaseWeight loss advice[††](#tbox1fndaggerdagger){ref-type="table-fn"}Reviewe-TemplateRecorded as verbal or written; or not appropriate[∗∗](#tbox1fnlowastlowast){ref-type="table-fn"}IncreaseWritten weight loss advice[††](#tbox1fndaggerdagger){ref-type="table-fn"}Guidelinee-TemplateRecorded as writtenIncreaseNon-pharmacological interventionsConsideration of physiotherapy referralGuidelinee-TemplateRecorded as offered; or not necessary or not appropriate[∗∗](#tbox1fnlowastlowast){ref-type="table-fn"}IncreasePhysiotherapy referral madeGuidelineRoutine EHRRecorded referral to physiotherapyIncreasePharmacological interventionsConsideration of paracetamol useReviewe-TemplateRecorded as tried, offered, or declined full dose; or not appropriate[‡‡](#tbox1fnddaggerddagger){ref-type="table-fn"}IncreaseParacetamol prescribedReviewRoutine EHRRecorded prescriptionIncreaseConsideration of topical NSAID useGuidelinee-TemplateRecorded as tried, offered or declined full dose; or not appropriate[‡‡](#tbox1fnddaggerddagger){ref-type="table-fn"}IncreaseTopical NSAID prescribedGuidelineRoutine EHRRecorded prescriptionIncreaseGastroprotection (PPI use with oral NSAIDs)ReviewRoutine EHRRecorded prescription (if oral NSAID prescribed)Increase[^1][^2][^3][^4][^5][^6][^7]Alt-text: Box 1

Recorded achievement of quality indicators was identified via two sources: information routinely entered in the EHR as part of standard care and that entered through an electronic template ("e-template") developed to allow clinicians to complete and capture information not routinely recorded ([Box 1](#tbox1){ref-type="boxed-text"}). The e-template was installed in all practices at the start of the six-month baseline period and was automatically triggered at any consultation with an entry of the same Read codes used to identify patients for the trial. Clinicians could choose to complete all, some, or none of the e-template. As previously reported, the e-template was found to be associated with an increased recording of weight and prescription of NICE-recommended first-line analgesics (paracetamol, topical NSAIDS) in the baseline period but other recorded care remained stable[@bib32].

Quality indicators could be achieved at the first consultation for clinical OA within the trial period or the following 120 days (to allow time for the patient to see the practice nurse). For indicators assessed through the routine record, they also had to be recorded within 14 days of a recorded consultation for clinical OA.

The percentage of patients in the intervention practices with a recorded practice nurse consultation (as directed in the model OA consultation) were identified from medical records as a measure of treatment fidelity.

Adverse events {#sec3.4}
--------------

Adverse events that may be related to the content of the model OA consultation and quality of care indicators were selected based on the NICE 2008 OA guidelines[@bib1] and recommendations of the Trial Steering Committee, and identified in the EHR from date of first OA consultation during the trial period up the last point of record download (31/8/2013).

Sample size {#sec3.5}
-----------

Sample size for the trial was based on the clinical effectiveness component[@bib17]. A priori, based on a 10% annual consultation prevalence for clinical OA in those aged ≥45[@bib22], and a population base of 30,000 adults aged ≥45 years across the eight general practices, we estimated there would be 3000 patients consulting annually for clinical OA.

Statistical analysis {#sec3.6}
--------------------

The analysis compared the intervention and control practices on recorded achievement of the individual quality indicators of care in patients consulting with clinical OA during the trial period (six months after randomisation and training). We determined practice-specific baseline levels of recorded quality indicator achievement. Baseline was taken as the first six months the e-template was introduced in the practices (prior to randomisation and training) and was based on patients with a recorded OA or joint pain code during that period. During the six month trial period, we identified the initial clinician recorded as seen by each patient for clinical OA in that period.

Multilevel logistic regression models (patients nested within initial clinician seen) were used to determine differences between intervention and control practices during the trial period in the achievement of each quality indicator. The models were adjusted for age, gender, whether the initial consultation was recorded as diagnosed OA or given a joint pain code, and baseline level of quality indicator achievement of the patient\'s practice. Results are presented as odds ratios (OR) with 95% CI.

Sensitivity analyses restricted the analysis to: (1) patients with at least one recorded entry on the e-template, (2) new consulters (defined as first clinical OA consultation since introduction of the e-template and with at least 365 days since any clinical OA consultation), (3) patients with a recorded diagnosis of OA.

To assess the likely effect of treatment fidelity, we descriptively compared recorded achievement of quality indicators, in the intervention practices only, between patients with a record of attendance at a practice nurse clinic and those without.

Differences in adverse events were analysed using chi-squared tests or Fisher\'s Exact Test as appropriate. Stata/MP 13.1, MLwiN v2.29 and the Stata command 'runmlwin' were used for the analyses[@bib33], [@bib34].

Results {#sec4}
=======

Mean registered populations for the practices were 10,240.5 (intervention) and 6983.3 (control). There were 1118 patients recorded with clinical OA during the six month trial period in the intervention practices, and 842 patients in the control practices ([Fig. 1](#fig1){ref-type="fig"}). Mean age of patients was 66.2 years (SD 12.34, intervention) and 66.5 (SD 11.93, control). 59% were female in the intervention practices, 61% in the control practices. The e-template fired for 1061 (95%) of the 1118 patients in the intervention practices and 757 (90%) of the 842 patients in the control practices. The reason for the template failing to fire for the remaining patients is unknown.Fig. 1Flowchart of practices and patients included in study.Fig. 1

41% (baseline) and 45% (trial period) of patients in the intervention practices received an OA diagnosis rather than a joint pain code compared to 23% and 29% in the control practices, respectively. During the trial period, there were 63 clinicians who first saw a patient in the intervention practices (seeing a median of 10 patients; IQR 2, 29) and 50 clinicians in the control practices (median 11 patients; IQR 2, 26).

Recorded achievement of quality indicators {#sec4.1}
------------------------------------------

There was wide variation in recorded achievement of the quality indicators during the baseline pre-randomisation period, measured through the e-template, between clinicians and between practices. For example, as previously reported[@bib32], in clinicians seeing more than the median number of clinical OA patients, a quarter failed to achieve any e-template measured indicator for more than half of their patients but another quarter achieved at least one indicator for more than 88% of their patients. This variation was reflected in wide baseline differences between the trial arms and there was a fall in recorded achievement of e-template measured indicators between baseline and trial period for both intervention and control practices, although this was not apparent in patients who had at least one entry on the e-template.

There were no statistically significant differences between intervention and control practices in the recorded achievement of the assessment quality indicators although X-ray requests reduced in the intervention arm (25--15%) but increased in the control practices (3--6%, OR 0.45; 95% CI 0.12, 1.72, [Table I](#tbl1){ref-type="table"}). There were also no statistically significant differences in the general indicators of core management. However, a record of the health care professional supplying written information on OA increased in the intervention practices from 4% of patients in the baseline period to 28% in the trial period and remained stable in the control practices (1--2%, OR 23.60, 95% CI 7.39, 75.40, [Table II](#tbl2){ref-type="table"}). Written exercise advice and written weight loss advice in those overweight also increased significantly in the intervention practices in comparison to the control practices.Table IComparison between intervention and control arms in recorded quality indicator achievementTable IDomainBaseline periodTrial periodOR[†](#tbl1fndagger){ref-type="table-fn"} (95% CI)ICC[‡](#tbl1fnddagger){ref-type="table-fn"}Intervention *n*[∗](#tbl1fnlowast){ref-type="table-fn"} (%)Control *n*[∗](#tbl1fnlowast){ref-type="table-fn"} (%)Intervention *n*[∗](#tbl1fnlowast){ref-type="table-fn"} (%)Control *n*[∗](#tbl1fnlowast){ref-type="table-fn"} (%)No. of consulters[∗∗](#tbl1fnlowastlowast){ref-type="table-fn"}1015/981836/7491118/1061842/757AssessmentPain assessment707 (72)390 (52)617 (58)318 (42)1.35 (0.58, 3.14)0.36Function assessment691 (70)384 (51)611 (58)309 (41)1.15 (0.49, 2.71)0.35Weight record278 (27)154 (18)309 (28)144 (17)1.36 (0.80, 2.33)0.20X-ray requested250 (25)22 (3)163 (15)47 (6)0.45 (0.12, 1.72)0.22Core managementInformation given578 (59)274 (37)554 (52)268 (35)1.34 (0.61, 2.96)0.34Exercise advice582 (59)285 (38)526 (50)246 (32)1.53 (0.75, 3.13)0.28Weight loss advice[††](#tbl1fndaggerdagger){ref-type="table-fn"}325 (53)159 (34)341 (49)136 (31)1.24 (0.61, 2.52)0.28Non-pharmacological managementPhysiotherapy referral considered426 (43)192 (26)348 (33)173 (23)1.45 (0.61, 3.40)0.29Physiotherapy referral made90 (9)35 (4)111 (10)19 (2)5.30 (2.11, 13.34)0.20Pharmacological managementParacetamol considered625 (64)349 (47)554 (52)284 (38)1.42 (0.71, 2.85)0.29Paracetamol prescribed164 (16)155 (19)241 (22)117 (14)1.74 (1.27, 2.38)0.03Topical NSAID considered540 (55)295 (39)501 (47)275 (36)0.97 (0.48, 1.95)0.28Topical NSAID prescribed267 (26)194 (23)327 (29)186 (22)1.21 (0.83, 1.76)0.09PPI prescribed[‡‡](#tbl1fnddaggerddagger){ref-type="table-fn"}63 (35)27 (23)69 (39)50 (36)0.92 (0.43, 1.98)0.14[^8][^9][^10][^11][^12][^13]Table IIRecorded achievement of quality indicators based on core NICE written recommendations by trial armTable IIBaseline periodTrial periodOR[∗](#tbl2fnlowast){ref-type="table-fn"} (95% CI)InterventionControlInterventionControl*n* (%)*n* (%)*n* (%)*n* (%)All consulters firing e-templateNo. of consulters9817491061757Written information36 (4)6 (0.8)296 (28)12 (2)23.60 (7.39, 75.40)Written exercise advice38 (4)8 (1)232 (22)7 (0.9)21.49 (6.62, 69.72)Written weight loss advice[†](#tbl2fndagger){ref-type="table-fn"}7 (1)1 (0.2)104 (15)2 (0.5)27.94 (3.56, 219.17)Coded with osteoarthritis diagnosisNo. of consulters410178483218Written information23 (6)2 (1)201 (42)7 (3)26.92 (6.33, 114.51)Written exercise advice24 (6)2 (1)158 (33)2 (0.9)40.49 (5.64, 290.56)Written weight loss advice[‡](#tbl2fnddagger){ref-type="table-fn"}7 (3)1 (0.9)79 (24)1 (0.8)[∗∗](#tbl2fnlowastlowast){ref-type="table-fn"}[^14][^15][^16][^17]

Physiotherapy referral remained stable in intervention practices (9% baseline, 10% trial period) and decreased slightly in control practices (4--2%; comparison in trial period between intervention practices and control practices: OR 5.30; 95% CI 2.11, 13.34). Prescribing of paracetamol increased from the baseline period in the intervention arm (16--22%) and decreased in the control arm (19--14%, OR 1.74; 95% CI 1.27, 2.38).

Restricting the analysis of indicators measured through the e-template to patients with at least one entry suggested a higher rate in the intervention practices of consideration of paracetamol use (OR 2.01; 95% CI 0.91, 4.41) and advice to exercise (OR 1.88; 95% CI 0.93, 3.79), albeit not statistically significant ([Appendix Table I](#appsec1){ref-type="sec"}). As in the main analysis, there were decreases from baseline in recorded achievement of the indicators measured through the e-template in new consulters and just those with an OA diagnosis. Restricting the analyses of indicators recorded through the routine records to new consulters for clinical OA did not change the findings from the main analysis ([Appendix Table II](#appsec1){ref-type="sec"}). In those with an OA diagnostic code only, patients in the intervention practices were additionally more likely to have their weight recorded (OR 3.07; 95% CI 1.37, 6.90) than those in the control practices ([Appendix Table III](#appsec1){ref-type="sec"}). There were larger increases in the intervention arm in those with an OA diagnosis for the core written aspects of management (written information 6--42%; written exercise advice 6--33%; written weight loss advice 3--24%) than seen in the main analysis ([Table II](#tbl2){ref-type="table"}).

220 (21%) of patients with clinical OA in the intervention practices had a record of attending a practice nurse clinic. There was a higher percentage of patients with an OA diagnosis in those attending the nurse clinic than in those who did not attend the nurse clinic (68% vs 40%). Except for physiotherapy referral and X-ray request, those who saw a practice nurse had higher levels of recorded achievement in indicators measured either through the routine records or through the e-template. In particular, 89% of those consulting a practice nurse received written information compared to 24% of those who did not (in those who had at least one entry on the e-template). There were also higher levels of written exercise advice (80% vs 13%) and written weight loss advice (44% vs 10%) ([Table III](#tbl3){ref-type="table"}).Table IIIRecorded quality indicator achievement in those attending nurse clinics and those who did not during trial period -- intervention arm only (4 practices)Table IIIDid not attend nurse clinicAttended nurse clinicAll *n*[∗](#tbl3fnlowast){ref-type="table-fn"} (%)≥1 e-template entry *n*[∗](#tbl3fnlowast){ref-type="table-fn"} (%)*n*[∗](#tbl3fnlowast){ref-type="table-fn"} (%)No. of consulters[†](#tbl3fndagger){ref-type="table-fn"}840416220AssessmentPain assessment398 (47)398 (96)218 (99)Function assessment392 (47)392 (94)218 (99)Weight record136 (16)N/A168 (76)X-ray requested118 (14)N/A36 (16)Core managementInformation given338 (40)338 (81)215 (98)Written information100 (12)100 (24)195 (89)Exercise advice309 (37)309 (74)216 (98)Written exercise advice55 (7)55 (13)177 (80)Weight loss advice[‡](#tbl3fnddagger){ref-type="table-fn"}193 (37)193 (69)147 (87)Written weight loss advice[‡](#tbl3fnddagger){ref-type="table-fn"}29 (5)29 (10)75 (44)Non-pharmacological managementPhysiotherapy referral considered215 (26)215 (52)132 (60)Physiotherapy referral made91 (11)N/A18 (8)Pharmacological managementParacetamol considered352 (42)352 (85)201 (91)Paracetamol prescribed160 (19)N/A76 (35)Topical NSAID considered316 (38)316 (76)184 (84)Topical NSAID prescribed219 (26)N/A94 (43)PPI[∗∗](#tbl3fnlowastlowast){ref-type="table-fn"} prescribed54 (38)N/A14 (45)[^18][^19][^20][^21]

Adverse events {#sec4.2}
--------------

An adverse event was recorded in 13% of patients in the intervention arm and 11% in the control arm ([Table IV](#tbl4){ref-type="table"}). Differences between arms were small and the one significant difference between arms was for heart failure (1.5% intervention arm vs 0.5% control arm). Of note, only two of the 17 patients with heart failure in the intervention arm had been prescribed either paracetamol or an oral NSAID for clinical OA during the trial period.Table IVComparison between intervention and control arms on adverse events recorded from first consultation for OA or joint pain in trial period to thirty first August 2013Table IVInterventionControl*P-*value[∗](#tbl4fnlowast){ref-type="table-fn"}No. of consulters1118842No. of days of follow-up Median (IQR)416 (360, 460)408 (355, 451)Death*n* (%)1 (0.1)1 (0.1)0.68Heart failure*n* (%)17 (1.5)4 (0.5)0.03[††](#tbl4fndaggerdagger){ref-type="table-fn"}New heart failure[†](#tbl4fndagger){ref-type="table-fn"}*n* (%)9 (0.8)0 (0)0.006[††](#tbl4fndaggerdagger){ref-type="table-fn"}Gastrointestinal*n* (%)9 (0.8)9 (1.1)0.54Renal impairment[†](#tbl4fndagger){ref-type="table-fn"}*n* (%)19 (1.7)11 (1.3)0.48Liver impairment/failure*n* (%)0 (0)0 (0)--Hypersensitivity[‡](#tbl4fnddagger){ref-type="table-fn"}*n* (%)1 (0.1)2 (0.2)0.40Asthma flare[†](#tbl4fndagger){ref-type="table-fn"}*n* (%)19 (1.7)20 (2.4)0.29Renal failure[∗∗](#tbl4fnlowastlowast){ref-type="table-fn"}*n* (%)2 (0.2)0 (0)0.33Myocardial infarction*n* (%)2 (0.2)5 (0.6)0.13Stroke*n* (%)14 (1.3)5 (0.6)0.14New stroke[†](#tbl4fndagger){ref-type="table-fn"}*n* (%)8 (0.7)2 (0.2)0.12Fall*n* (%)65 (5.8)39 (4.6)0.25Infection*n* (%)6 (0.5)1 (0.1)0.12Deep vein thrombosis*n* (%)0 (0)0 (0)--Leg amputation*n* (%)0 (0)1 (0.1)0.43Septic arthritis*n* (%)0 (0)0 (0)--Any adverse event*n* (%)146 (13.1)96 (11.4)0.27[^22][^23][^24][^25][^26]

Discussion {#sec5}
==========

A model OA consultation, informed by NICE recommendations and incorporating an enhanced initial GP consultation, nurse-led OA clinic, and OA Guidebook, compared with usual care, substantially increased uptake of core written non-pharmacological recommendations, though there remained scope for further improvement. The model OA consultation produced higher levels of prescribing of simple analgesia (paracetamol) and physiotherapy referral. There was a reduction in referral for X-ray in the intervention practices (although not statistically significant) and little evidence that the model OA consultation was associated with a higher number of adverse events. However, wide variation in recorded management was identified and evidence of improvement in recorded achievement was not consistent across all indicators.

A novelty of our study was use of anonymised practice-level data to study the effect of the intervention on all patients consulting with OA or joint pain. Uptake of recommended NICE management of OA were measured using previously identified quality indicators of OA care[@bib31] captured via an e-template, and routinely recorded information. To enhance the uptake of NICE OA recommendations we used theory-derived interventions, clinical champions, outreach visits, theory-informed training, funded practice nurse clinics, supply of high quality patient information, and a model OA consultation to deliver evidence-based recommendations. The extent to which each of these approaches contributed independently cannot be determined. The model OA consultation had a strong theoretical underpinning using the WISE model to define self-management and patient information and the Theoretical Domains Framework to develop training to deliver the consultation[@bib13], [@bib16].

Our earlier work had shown that the template was a feasible way for GPs to record care, and that the introduction of the template alone had positive effects on quality care such as prescribing[@bib32]. Introducing the model OA consultation had no discernible additional influence on the level of recording of items on the e-template beyond baseline. However, despite the limited number of practices in the trial and wide variation across practices, there was an important and statistically significant improvement in a key component of NICE guidance, namely the provision of written information about OA and written advice about exercise and weight control, in the intervention compared with control practices.

A strength was introduction of the e-template and familiarisation six months prior to randomisation to capture for the first time information on recommended indicators of quality of care not routinely captured in the EHR. The e-template alone increased the use of topical NSAIDS[@bib32] which reduced the likelihood of detecting further increases as a result of the model OA consultation. Use of paracetamol also showed a trend in favour of increased use in the baseline period, however there was a further statistically significant increase in use following implementation of the model OA consultation. The template failed to fire for a small group of patients. Whilst the reason for this is unknown, it is unlikely to have introduced any bias. The baseline level of achievement in various domains pre-randomisation was already high when compared with other published estimates of recorded quality of care[@bib4], [@bib5], [@bib7], [@bib8]. Levels of achievement of OA quality indicators as measured through the e-template fell generally from baseline levels, possibly due to initiative fatigue in use of the template. On completion of the research however seven of the eight practices chose to continue with the e-template. We also, in a sensitivity analysis, restricted analysis to patients with at least one e-template entry to try and overcome some of the influence of the fall in overall recording. However, the higher baseline levels of quality achievement compared to previous estimates, general fall in recording, and baseline variation between practices and health care professionals limited investigation of the potential effect of the intervention. There was an imbalance in the number of patients between arms due to the inclusion of one much larger practice. We included patients with consultations coded as knee, hip, hand/wrist and foot/ankle pain, as non-specific pain at these sites in older adults is most likely to be underlying OA. Recorded joint pain in other sites which may present as OA (shoulder and elbow) were not included, however these sites made up just 2% of OA diagnosed consultations during the trial period. In the analysis, we clustered patients within clinicians rather than practices. We performed a sensitivity analysis (data not shown) with practice as an extra level in the multilevel models. This showed the majority of variation was at clinician level and did not change the findings. The extent to which the recorded quality of care reflects the actual delivery of care is not known. Given quality of care is necessarily measured across several indicators, the testing of multiple comparisons could not be avoided and increased the possibility that identified differences between arms were due to chance.

Only 21% of patients in the intervention arm attended the practice nurse clinics. Referral by the GP and attendance by the patient were optional. Patients with an OA diagnosis were more likely to attend and had increased uptake of core treatments suggesting that making a formal OA diagnosis was linked to management. It is possible those given an OA diagnosis have more severe pain or functional limitation although other work suggests that known risk factors (older age, obesity) are more strongly linked to OA diagnosis than severity[@bib20].

The provision of OA guidebooks in the intervention arm was captured by the increased uptake of written information on OA. This is an important outcome for the trial given the recent NICE Quality Standards for OA which highlights the importance of providing written information about OA and its management[@bib35]. Access to weight loss advice and support is recommended in the NICE guidance and is regarded as a care quality indicator[@bib31]. The increased use of written weight loss advice is another strength of the intervention. Previous studies have shown reliance by GPs on pharmacological management of OA[@bib3], so the increase in these non-pharmacological core interventions is encouraging. Further work is required to understand the extent to which provision of written information and advice affects patient outcomes. X-ray use declined in the intervention arm which is in line with NICE recommendations.

There was an increased incidence of heart failure in the intervention arm. As only two of the 17 patients with heart failure had been prescribed paracetamol or oral NSAIDs, it seems unlikely that this is due to a pharmacological effect, and it seems clinically implausible that the noted statistically significant difference is caused by the intervention.

In our novel practice-level analysis of anonymised data from all consulters with OA and joint pain, we have shown that a model OA consultation intervention which provides additional resources for a primary care-based OA service, notably a patient guidebook and practice nurse referral clinics, did not lead to improvements on all indicators of quality of OA care. However there was improved achievement of NICE guidance targets for written information and advice, and some small but additional beneficial effects on prescribing and referrals.
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[^1]: PPI = proton pump inhibitor. Clinicians were asked to record "not appropriate" when they considered a patient not eligible for a process of care.

[^2]: Systematic review[@bib31] or NICE guideline[@bib1], indicators taken from routine record had to be within 14 days of a clinical OA consultation.

[^3]: Compared to control group.

[^4]: None, mild, moderate, severe.

[^5]: Not this time or no entry indicates non-achievement.

[^6]: In those with recorded BMI ≥ 25 in previous 3 years.

[^7]: Unknown or no entry indicates non-achievement.

[^8]: Number of patients with record of achievement of indicator.

[^9]: Adjusted for age, gender, coded OA or joint pain, practice level of achievement in baseline period and accounting for clustering by clinician, reference is control group.

[^10]: Estimated intraclass correlation coefficient based on adjusted model.

[^11]: Number consulting for clinical OA in trial period and hence with routine record information/number for whom e-template fired.

[^12]: In those recorded as overweight: baseline period intervention *n* = 615, control *n* = 470; trial period intervention *n* = 698, control *n* = 439.

[^13]: On date of NSAID prescription in those prescribed oral NSAIDs: baseline period intervention *n* = 181, control *n* = 119; trial period intervention *n* = 176, control *n* = 137. PPI = proton pump inhibitor.

[^14]: Adjusted for age, gender, coded OA or joint pain, practice level of achievement in baseline period and accounting for clustering by clinician, reference is control group.

[^15]: In those recorded as overweight: baseline period intervention *n* = 615, control *n* = 470; trial period intervention *n* = 698, control *n* = 439.

[^16]: In those recorded as overweight: baseline period intervention *n* = 272, control *n* = 114; trial period intervention *n* = 335, control *n* = 132.

[^17]: Model failed to converge.

[^18]: Number (%) of patients with record of achievement of indicator.

[^19]: One patient excluded as recorded nurse clinic was before start of analysis period.

[^20]: In those recorded as overweight: not attended nurse clinic *n* = 528, not attended nurse clinic but at least 1 e-template entry *n* = 279, attended nurse clinic *n* = 169.

[^21]: In those prescribed NSAID, not attended nurse clinic *n* = 142, attended nurse clinic = 32. PPI = proton pump inhibitor. N/A = not applicable as quality achievement assessed using routine records.

[^22]: Chi-squared Test or Fisher\'s Exact Test as appropriate.

[^23]: New cases only, no record in 2 years prior to index date.

[^24]: Includes angioedema and new cases of wheeze (no record in 2 years prior to index date).

[^25]: Acute renal failure or chronic renal failure with no record of renal failure in 2 years prior to index date.

[^26]: *P* \< 0.05. Index date = date of first consultation for OA or joint pain in trial period.
